Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neuroblastoma breakpoint family member 13, pseudogene (NBPF13P) is a non-coding pseudogene in the NBPF gene family located on human chromosome 1. The NBPF gene family is associated with domains of unknown function (DUF1220), and certain members, such as NBPF1, have been studied for possible roles in neuroblastoma and other cancers[2][3][4][5][7][8]. However, NBPF13P itself contains numerous nonsense mutations in various exons, lacks protein-coding capacity, and does not have evidence of biological activity, therapeutic targeting, or drug interactions[1][3][4][5]. It is grouped with other NBPF pseudogenes by evolutionary history but is not considered a functional or druggable target[1][2][5][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neuroblastoma breakpoint family member 13, pseudogene (NBPF13P).